LONZA
LIVE

Serial Number

79389966

Owner

LONZA LTD.

Attorney

Lawrence J. Crain

Filing Date

Oct 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LONZA Trademark

Serial Number: 79389966 • Registration: 7656626

LONZA is a trademark filed by LONZA LTD. on October 12, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LONZA LTD. (134 trademarks)

BASLE SWITZERLAND

Entity Type: 98

Trademark Details

Filing Date

October 12, 2023

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use; biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel, powder, and liquid or as food additives

Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, animal and synthetic proteins for commercial use, other than for medical or veterinary use; biological preparations for use in industry and science, namely, blood, tissue, blood cells and human or animal stem cells, for commercial use; biological preparations for use in industry and science, namely, bioconjugates for drug development; biological preparations for use in industry and science, namely, primary cells, cell cultures and transfection animal tissue for commercial use in human and animal therapies; biopharmaceutical chemicals, namely, monoclonal antibodies and proteins for scientific and pharmaceutical research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2024 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2024 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2024 CNRT
ASSIGNED TO LIE
Jun 17, 2024 ALIE
REFUSAL PROCESSED BY IB
May 1, 2024 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2024 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2024 CRFA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2024 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 27, 2024 MAFR
ASSIGNED TO EXAMINER
Feb 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 22, 2024 REPR